Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Weiner, E. Articles by Buchanan, R. W. Search for Related Content PubMed Citation Articles by Weiner, E. Articles by Buchanan, R. W. Neuropsychology Nicotine Schizophrenia Spectrum Disorders Other Psychotherapy Antidepressants

Effects of Sustained-Release Bupropion and Supportive Group Therapy on Cigarette Consumption in Patients With Schizophrenia

OBJECTIVE: The study examined the efficacy, tolerability, and safety of supportive group psychotherapy and adjunctive sustained-release bupropion for nicotine addiction in patients with schizophrenia. METHOD: Eight patients participated in a 14-week open-label trial. End expired breath carbon monoxide level, symptom levels, neuropsychological performance, and suppression of the P50 event-related potential were measured before and after the 14-week trial. RESULTS: Patients showed a decrease in carbon monoxide levels that was not associated with any worsening in symptom, neuropsychological, or P50 suppression measures. CONCLUSIONS: Use of sustained-release bupropion in combination with supportive group therapy may help patients with schizophrenia decrease their cigarette consumption.

This article has been cited by other articles:

				T. V. Cooper, B. S. Hanson, R. S. Burke, and Y. M. Hunt Sequential Treatment for Nicotine Dependence and Postcessation Weight Concern in a Female Diagnosed with Paranoid Schizophrenia Clinical Case Studies, August 1, 2008; 7(4): 340 - 355. [Abstract] [PDF]

				B. I. Turetsky, M. E. Calkins, G. A. Light, A. Olincy, A. D. Radant, and N. R. Swerdlow Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures Schizophr Bull, January 1, 2007; 33(1): 69 - 94. [Abstract] [Full Text] [PDF]

				A. Baker, R. Richmond, M. Haile, T. J. Lewin, V. J. Carr, R. L. Taylor, S. Jansons, and K. Wilhelm A Randomized Controlled Trial of a Smoking Cessation Intervention Among People With a Psychotic Disorder Am J Psychiatry, November 1, 2006; 163(11): 1934 - 1942. [Abstract] [Full Text] [PDF]

				A. R. Lingford-Hughes, S. Welch, and D. J. Nutt Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, September 1, 2004; 18(3): 293 - 335. [PDF]

				B. Spring, R. Pingitore, and D. E. McChargue Reward Value of Cigarette Smoking for Comparably Heavy Smoking Schizophrenic, Depressed, and Nonpatient Smokers Am J Psychiatry, February 1, 2003; 160(2): 316 - 322. [Abstract] [Full Text] [PDF]

				N. el-Guebaly, J. Cathcart, S. Currie, D. Brown, and S. Gloster Smoking Cessation Approaches for Persons With Mental Illness or Addictive Disorders Psychiatr Serv, September 1, 2002; 53(9): 1166 - 1170. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us